Sensabues AB offers a newly discovered, novel and proprietary procedure for the collection, detection and identification of non-volatile substances in exhaled breath. These can be exogenous substances, such as drugs of abuse (narcotics), therapeutic drugs (antibiotics) and performance enhancing drugs (stimulants). Also, they can be endogenous substances associated with the study of metabolomics and the determination of biomarkers.

This exhaled breath based biomatrix platform, ExaBreath® (EB), is transforming drug detection, health monitoring and medical diagnostics for:

  • sports doping control
  • drugs of abuse testing
  • therapeutic drug monitoring
  • biomarker detection

EB is achieving this by:

  • lowering the cost of sample collection
  • reducing specimen sampling collection time and complexity
  • making specimen sampling collection more convenient and less intrusive
  • increasing the acceptability and frequency of sample collection
  • enabling new types of collection procedures